Greg Abel knows Berkshire cold, but some miss the Buffett magic

Berkshire reported a muted first-quarter update: A shares rose 1% on the week, B shares gained 0.6%, while the S&P 500 was up 2.3%. Investors also noted just $234 million of Q1 buybacks despite Berkshire's March announcement that repurchases had resumed, alongside continued uncertainty around the investment portfolio and cash pile of about $397.4 billion ($380.2 billion excluding rail cash and T-bills payable). The piece also highlights Greg Abel's solid but less charismatic debut as CEO, a planned insurance succession for Charlie Shamieh, and Berkshire's large Japan stakes rising above 10%.

Analysis

The key market signal is not the personality transition; it is the widening gap between Berkshire’s operating excellence and its capital-allocation under-earnings. A company that can explain every subsidiary in detail but still sits on an unusually large liquidity buffer with minimal repurchases is effectively telegraphing that intrinsic value may be growing slower than headline asset value, which tends to cap multiple expansion even when earnings are stable.

That creates a second-order issue for holders of Berkshire-adjacent capital. If the market starts treating BRK.B less like a quasi-cash compounder and more like a mature conglomerate with an execution premium, the relative winner becomes any company that can credibly return cash at scale and provide a clearer capital-redeployment roadmap. In that framework, the unresolved succession around insurance also matters: insurance is the central float engine, so any perceived pause in decision quality there compresses Berkshire’s “optionality premium” before it shows up in reported results.

The DaVita sale is mechanically forced, but economically it highlights a hidden advantage of Berkshire’s structure: it can be compelled to sell into strength and still avoid signaling distress. That said, the market may overreact to the loss of optionality around concentrated positions if investors extrapolate forced trimming into broader portfolio rigidity. Conversely, the Japan stakes crossing 10% reinforces that Berkshire still prefers long-duration, cash-generative balance-sheet assets when U.S. large-cap valuations are unattractive.

The contrarian take is that the market may be underestimating how much of Berkshire’s future return will come from boring, not brilliant, capital allocation. If Abel sustains operational discipline and simply avoids mistake risk, the stock can still compound; the near-term disappointment is mostly about lost narrative, not impaired earning power. The risk is that narrative erosion can persist for quarters and keep BRK.B trapped in a low-volatility, low-re-rating regime while the S&P outperforms.

Key Decisions for Investors

• Underweight BRK.B versus S&P 500 for the next 3-6 months: the stock likely remains capped by weak capital-return optics and a lower narrative premium; use any rally toward 1.4-1.5x book-equivalent sentiment highs to trim.
• Pair trade: long DVA / short BRK.B into the next 1-2 quarters. DVA has a clearer earnings/operating catalyst and benefits from forced Berkshire selling into strength; risk is valuation overshoot after the recent move.
• Buy BRK.B on deep pullbacks only, not on the meeting headline. The right entry is a volatility event or broader market selloff that pushes implied expectations lower; absent that, upside appears more defensive than offensive.
• If seeking Berkshire exposure, prefer the Japanese trading-house complex via indirect vehicles or local listings over BRK.B for the next 6-12 months: Berkshire is signaling conviction there, but the stock market has not fully discounted the steady compounding of those stakes.
• Hedge a BRK.B position with short-dated put spreads around the next capital-allocation catalyst window (next earnings / buyback update). The thesis is not collapse; it is multiple compression if buybacks remain token.